vs
Side-by-side financial comparison of Cytek Biosciences, Inc. (CTKB) and MID PENN BANCORP INC (MPB). Click either name above to swap in a different company.
Cytek Biosciences, Inc. is the larger business by last-quarter revenue ($62.1M vs $62.0M, roughly 1.0× MID PENN BANCORP INC). MID PENN BANCORP INC runs the higher net margin — 31.4% vs -70.9%, a 102.3% gap on every dollar of revenue. On growth, MID PENN BANCORP INC posted the faster year-over-year revenue change (30.8% vs 8.1%). MID PENN BANCORP INC produced more free cash flow last quarter ($71.8M vs $-1.8M). Over the past eight quarters, MID PENN BANCORP INC's revenue compounded faster (21.1% CAGR vs 17.7%).
Cytek Biosciences, Inc. develops, manufactures and sells high-performance flow cytometry systems, associated reagents and analysis software. Its solutions serve life science research, clinical diagnostics and biopharmaceutical sectors, with a global customer base across North America, Europe and the Asia-Pacific region.
Commerce Bancorp was a Cherry Hill, New Jersey–based bank created in 1973. In 2007, it was purchased by Toronto-Dominion Bank, which merged Commerce into TD Banknorth, the latter of which was rebranded to TD Bank.
CTKB vs MPB — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $62.1M | $62.0M |
| Net Profit | $-44.1M | $19.4M |
| Gross Margin | 52.9% | — |
| Operating Margin | -9.0% | 43.6% |
| Net Margin | -70.9% | 31.4% |
| Revenue YoY | 8.1% | 30.8% |
| Net Profit YoY | -557.1% | 47.0% |
| EPS (diluted) | — | $0.83 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $62.1M | $62.0M | ||
| Q3 25 | $52.3M | $61.8M | ||
| Q2 25 | $45.6M | $54.3M | ||
| Q1 25 | $41.5M | $47.7M | ||
| Q4 24 | $57.5M | $47.4M | ||
| Q3 24 | $51.5M | $45.3M | ||
| Q2 24 | $46.6M | $44.1M | ||
| Q1 24 | $44.9M | $42.3M |
| Q4 25 | $-44.1M | $19.4M | ||
| Q3 25 | $-5.5M | $18.3M | ||
| Q2 25 | $-5.6M | $4.8M | ||
| Q1 25 | $-11.4M | $13.7M | ||
| Q4 24 | $9.6M | $13.2M | ||
| Q3 24 | $941.0K | $12.3M | ||
| Q2 24 | $-10.4M | $11.8M | ||
| Q1 24 | $-6.2M | $12.1M |
| Q4 25 | 52.9% | — | ||
| Q3 25 | 52.7% | — | ||
| Q2 25 | 52.3% | — | ||
| Q1 25 | 48.6% | — | ||
| Q4 24 | 58.5% | — | ||
| Q3 24 | 56.3% | — | ||
| Q2 24 | 54.6% | — | ||
| Q1 24 | 51.3% | — |
| Q4 25 | -9.0% | 43.6% | ||
| Q3 25 | -17.6% | 39.3% | ||
| Q2 25 | -23.3% | 7.9% | ||
| Q1 25 | -36.1% | 35.2% | ||
| Q4 24 | 5.2% | 34.1% | ||
| Q3 24 | -8.2% | 32.8% | ||
| Q2 24 | -18.3% | 32.4% | ||
| Q1 24 | -23.9% | 34.8% |
| Q4 25 | -70.9% | 31.4% | ||
| Q3 25 | -10.5% | 29.6% | ||
| Q2 25 | -12.2% | 8.8% | ||
| Q1 25 | -27.5% | 28.8% | ||
| Q4 24 | 16.8% | 27.9% | ||
| Q3 24 | 1.8% | 27.1% | ||
| Q2 24 | -22.4% | 26.7% | ||
| Q1 24 | -13.8% | 28.7% |
| Q4 25 | — | $0.83 | ||
| Q3 25 | — | $0.79 | ||
| Q2 25 | — | $0.22 | ||
| Q1 25 | — | $0.71 | ||
| Q4 24 | — | $0.72 | ||
| Q3 24 | — | $0.74 | ||
| Q2 24 | — | $0.71 | ||
| Q1 24 | — | $0.73 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $90.9M | — |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $341.7M | $814.1M |
| Total Assets | $461.5M | $6.1B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $90.9M | — | ||
| Q3 25 | $93.3M | — | ||
| Q2 25 | $75.5M | — | ||
| Q1 25 | $95.3M | — | ||
| Q4 24 | $98.7M | — | ||
| Q3 24 | $162.3M | — | ||
| Q2 24 | $177.9M | — | ||
| Q1 24 | $168.8M | — |
| Q4 25 | $341.7M | $814.1M | ||
| Q3 25 | $378.6M | $796.3M | ||
| Q2 25 | $377.6M | $775.7M | ||
| Q1 25 | $379.6M | $667.9M | ||
| Q4 24 | $395.7M | $655.0M | ||
| Q3 24 | $385.5M | $573.1M | ||
| Q2 24 | $389.1M | $559.7M | ||
| Q1 24 | $392.6M | $551.0M |
| Q4 25 | $461.5M | $6.1B | ||
| Q3 25 | $494.9M | $6.3B | ||
| Q2 25 | $493.3M | $6.4B | ||
| Q1 25 | $482.6M | $5.5B | ||
| Q4 24 | $499.5M | $5.5B | ||
| Q3 24 | $491.2M | $5.5B | ||
| Q2 24 | $483.7M | $5.4B | ||
| Q1 24 | $492.1M | $5.3B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-771.0K | $80.0M |
| Free Cash FlowOCF − Capex | $-1.8M | $71.8M |
| FCF MarginFCF / Revenue | -2.9% | 115.8% |
| Capex IntensityCapex / Revenue | 1.6% | 13.3% |
| Cash ConversionOCF / Net Profit | — | 4.12× |
| TTM Free Cash FlowTrailing 4 quarters | $-8.8M | $132.1M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-771.0K | $80.0M | ||
| Q3 25 | $-3.9M | $26.3M | ||
| Q2 25 | $108.0K | $29.0M | ||
| Q1 25 | $-125.0K | $11.5M | ||
| Q4 24 | $2.0M | $51.4M | ||
| Q3 24 | $13.2M | $16.9M | ||
| Q2 24 | $6.2M | $18.0M | ||
| Q1 24 | $4.0M | $12.4M |
| Q4 25 | $-1.8M | $71.8M | ||
| Q3 25 | $-4.6M | $24.3M | ||
| Q2 25 | $-1.5M | $27.2M | ||
| Q1 25 | $-974.0K | $8.8M | ||
| Q4 24 | $1.1M | $44.5M | ||
| Q3 24 | $12.2M | $16.8M | ||
| Q2 24 | $5.2M | $17.7M | ||
| Q1 24 | $3.4M | $12.1M |
| Q4 25 | -2.9% | 115.8% | ||
| Q3 25 | -8.7% | 39.4% | ||
| Q2 25 | -3.2% | 50.1% | ||
| Q1 25 | -2.3% | 18.4% | ||
| Q4 24 | 1.9% | 93.8% | ||
| Q3 24 | 23.7% | 37.1% | ||
| Q2 24 | 11.0% | 40.2% | ||
| Q1 24 | 7.6% | 28.5% |
| Q4 25 | 1.6% | 13.3% | ||
| Q3 25 | 1.3% | 3.1% | ||
| Q2 25 | 3.5% | 3.2% | ||
| Q1 25 | 2.0% | 5.7% | ||
| Q4 24 | 1.6% | 14.6% | ||
| Q3 24 | 2.0% | 0.0% | ||
| Q2 24 | 2.3% | 0.7% | ||
| Q1 24 | 1.3% | 0.8% |
| Q4 25 | — | 4.12× | ||
| Q3 25 | — | 1.44× | ||
| Q2 25 | — | 6.08× | ||
| Q1 25 | — | 0.84× | ||
| Q4 24 | 0.21× | 3.88× | ||
| Q3 24 | 14.05× | 1.37× | ||
| Q2 24 | — | 1.53× | ||
| Q1 24 | — | 1.02× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CTKB
| Products | $46.6M | 75% |
| Services | $15.5M | 25% |
MPB
Segment breakdown not available.
